Schizophrenia Spectrum and Other Psychotic Disorders: all 84 studies

Page 1 of 1. Open to participants first (14), then studies with results posted, then the rest; newest registration first within each.

• REFLECT: A Novel Group-Based Compassion-Focussed Cognitive Behavioural Approach to Core Beliefs in PsychosisRecruitingNCT07569471Not applicable
• An Open-Label Study of ML-007C-MA in Adults With Alzheimer's Disease PsychosisEnrolling by invitationNCT07459660Phase 2
• Study Comparing Antipsychotic Dose Reduction vs. Maintenance Treatment in Patients With Schizophrenia Spectrum Disorder: a Personalized Medicine ApproachNot yet recruitingNCT07152184Phase 2
• Effects of Tirzepatide on Alcohol Intake in Patients Diagnosed With Schizophrenia and Alcohol Use DisorderRecruitingNCT06939088Phase 2
• A Study to Assess the Efficacy and Safety of ML-007C-MA for the Treatment of Alzheimer's Disease PsychosisRecruitingNCT06887192Phase 2
• Karolinska Schizophrenia ProjectRecruitingNCT06872463
• Biomarkers/Biotypes, Course of Early Psychosis and Specialty ServicesRecruitingNCT06740383
• Immunoinflammatory State Detection and Multimodal Brain Imaging and Electrophysiologic Changes in SchizophreniaRecruitingNCT06673966
• Effectiveness of a Pragmatic, Metabolic Care Clinic for Patients With Severe Mental Illness - The Meta Care ClinicRecruitingNCT06624462Not applicable
• The Personalized Psychological Treatment for PsychosisNot yet recruitingNCT06603922Not applicable
• SloMo2: Implementation, Effectiveness, and Cost-effectiveness StudyRecruitingNCT06568081Not applicable
• VR-based Avatar Therapy for Treatment of Auditory HallucinationsRecruitingNCT06505564Not applicable
• Sex, Psychopharmacology, and DiabetesRecruitingNCT05951660Not applicable
• Cigarette Consumption After switchinG to High or Low Nicotine strENght E-cigaretteS In Smokers With SchizophreniaRecruitingNCT04452175Not applicable
• Music Therapy Advocacy Recording Intervention (MTAR) on Internalized StigmaTerminatedNCT05723328Not applicableResults posted
• A Study to Evaluate Safety and Tolerability of CVL-231 (Emraclidine) in Adult Participants With SchizophreniaTerminatedNCT05443724Phase 2Results posted
• A Trial of 15 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With SchizophreniaCompletedNCT05227703Phase 2Results posted
• A Trial of 10 and 30 mg Doses of CVL-231 (Emraclidine) in Participants With SchizophreniaCompletedNCT05227690Phase 2Results posted
• Family Psychoeducation for Adults With Psychotic Disorders in TanzaniaCompletedNCT04013932Not applicableResults posted
• Rituximab for Schizophrenia Spectrum Disorder (RITS-PS-2019)CompletedNCT03983018Phase 2Results posted
• Repetitive TMS & Cognitive Training in Adults With SchizophreniaTerminatedNCT03741751Not applicableResults posted
• Feasibility and Outcomes of a Digital Health Support for the Schizophrenia SpectrumCompletedNCT03649815Early Phase 1Results posted
• Biomarkers of Conversion Risk and Treatment Response in Early-Stage SchizophreniaCompletedNCT03323437Phase 4Results posted
• An Active-Controlled Early Phase Study of Elpipodect (MK-8189) in Adults With Schizophrenia (MK-8189-005)CompletedNCT03055338Phase 2Results posted
• PACT for Individuals With Serious Mental IllnessCompletedNCT01668355Not applicableResults posted
• D-cycloserine Augmentation of Cognitive Remediation in SchizophreniaCompletedNCT00963924Not applicableResults posted
• One-Year Trial Of Oral Ziprasidone In Patients With Metabolic SyndromeTerminatedNCT00748566Phase 4Results posted
• Specialized Treatment Early in Psychosis (STEP)CompletedNCT00309452Not applicableResults posted
• Contingent Incentives Plus Bupropion for Smoking in People With SchizophreniaCompletedNCT00136760Phase 2Results posted
• Benefits of Combining MCT With CR in the Recovery of Patients With Psychotic Spectrum DisordersStatus unknownNCT06423651Not applicable
• Antipsychotic Induced Hyperprolactinemaia as Risk Factor for Periodontitis in Schizophrenic PatientsCompletedNCT06040944
• EPI-MINN: Targeting Cognition and Motivation - NationalActive, not recruitingNCT05877716Not applicable
• State Representation in Early Psychosis - Project 4CompletedNCT05664594Not applicable
• A Randomized Controlled Trial With Rituximab for Psychotic Disorder in AdultsActive, not recruitingNCT05622201Phase 2
• Ascertaining Diagnosis Classification With Elicited SpeechCompletedNCT05601063
• Remote State Representation in Early PsychosisCompletedNCT05538832Early Phase 1
• Mindfulness, Empathy and the Oxytocinergic System in Persons With SchizophreniaStatus unknownNCT05491486Not applicable
• Study to Evaluate the PK Profiles of LY03010 in Patients With Schizophrenia or Schizoaffective DisorderCompletedNCT05321602Phase 1
• Community Reinforcement Approach and Family Training for Substance Use in Early Psychosis InterventionCompletedNCT05300633Not applicable
• State Representation in Early PsychosisCompletedNCT05273164
• Plan D- Vitamin D Supplementation in Psychotic DisordersCompletedNCT05211635Not applicable
• Pharmacokinetics of CVL-231 Following Single Oral Administration of Modified- and Immediate-release Formulations in Fasted and Fed Healthy ParticipantsCompletedNCT05106309Phase 1
• Acceptance and Commitment Therapy-based Lifestyle Counselling Programme for Early Psychosis on Physical ActivityCompletedNCT04916496Not applicable
• Personalizing Interventions Using Real-World InteractionsCompletedNCT04665401Not applicable
• Efficacy of Prebiotic and Probiotic Dietary Modulation in Schizophrenic DisordersCompletedNCT04366401Not applicable
• ED to EPI: Using SMS to Improve the Transition From the Emergency Department to Early Psychosis InterventionCompletedNCT04298450Not applicable
• Metacognitive Training and Insight in SchizophreniaStatus unknownNCT04104347Not applicable
• OnTrackNY's Learning Healthcare SystemSuspendedNCT04021719
• Insight Enhancement Program vs. Metacognitive Training for Psychosis in Patients With Schizophrenia: A Three-Armed Comparative Randomized Controlled TrialCompletedNCT03955549Phase 3
• Early Psychosis Intervention - Spreading Evidence-based TreatmentCompletedNCT03919760Not applicable
• Cognitive Behavior Therapy for Patients With Psychoses.CompletedNCT03501888Not applicable
• Multi-dimensional Investigations of Negative Emotions and Drug-resistant Auditory Verbal Hallucinations in PsychosisCompletedNCT03449407
• Mirror-image Study of Paliperidone Palmitate and Risperidone Long-acting InjectionStatus unknownNCT03390712
• Effectiveness of a Mindfulness-based Group Training Addressing Social Cognition in First Episode Psychosis (AGES-Mind)CompletedNCT03309475Not applicable
• Randomized Controlled Trial of Pyridoxine for Tardive DyskinesiaCompletedNCT03287778Not applicable
• Phenomics and Genomics of Clozapine PharmacotherapyStatus unknownNCT03253367
• Copeptin in Outcome Prediction of an Acute Psychotic EpisodeCompletedNCT03235908
• Video Games Among People With SchizophreniaCompletedNCT03133143Not applicable
• 10-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis IndividualsStatus unknownNCT03090490Not applicable
• Testing a New Device to Advance the Use of Social Skills Training With Mental Health Consumers and CliniciansCompletedNCT03053557Not applicable
• Berberine as Adjuvant Treatment for Schizophrenia PatientsCompletedNCT02983188Phase 2/3
• The Benefit of Minocycline on Negative Symptoms in Schizophrenia: Extent and MechanismsCompletedNCT02928965Phase 2
• Low Pulse Amplitude Seizure Therapy (LAP-ST Study)CompletedNCT02928159Phase 1
• Study of the Activation of Proinflammatory Pathways of Toll-like Receptors in Schizophrenia PatientsCompletedNCT02897167
• Anomalous Self-Experience in First Episode Psychosis - A Six-Year Follow-Up StudyCompletedNCT02321943
• Implementation and Evaluation of a Family-based Intervention Program for Children of Mentally Ill ParentsCompletedNCT02308462Not applicable
• Evaluation of the Necessity of Long-term Pharmacological Treatment With Antipsychotics in Schizophrenic PatientsCompletedNCT02307396Phase 4
• Compensatory Cognitive Training in Clinical High Risk Latino YouthStatus unknownNCT02245607Not applicable
• Antipsychotic Effects of Sorghum Bicolor (JOBELYN) in the Treatment of SchizophreniaStatus unknownNCT02240173Phase 1/2
• 3-year Follow-up of Clinical Outcome After Antipsychotic Treatment Discontinuation in Psychosis IndividualsCompletedNCT02220504Not applicable
• Critical Time Intervention-Task Shifting: Randomized Controlled TrialCompletedNCT01995864Not applicable
• Investigator Initiated Study - Asenapine Early PsychosisStatus unknownNCT01968161Phase 4
• A Study to Assess the Relative Bioavailability of a Modified-Release Formulation of PF-05180999CompletedNCT01530529Phase 1
• A Large Pragmatic Cluster Randomized Controlled Trial of a Multi-element Psychosocial Intervention for Early PsychosisCompletedNCT01436331Not applicable
• Duration of Untreated Psychosis (DUP) and Pathways to Care in NordlandCompletedNCT01196858
• Effects of Delta-9-THC and Iomazenil in Healthy HumansCompletedNCT00982982Early Phase 1
• Medication Adherence in Schizophrenia: Development of a CBT-Based InterventionCompletedNCT00980252Not applicable
• Once Weekly D-cycloserine for SchizophreniaWithdrawnNCT00964041Phase 4
• Social Skills Training in Refractory SchizophreniaStatus unknownNCT00791882Not applicable
• Side Effects of Antipsychotic MedicationsCompletedNCT00363181
• A Clinical Trial on the Antipsychotic Properties of CannabidiolCompletedNCT00309413Phase 2
• Effects of Transdermal Nicotine on Smoking, Craving and Withdrawal in People With SchizophreniaCompletedNCT00218218Phase 2
• Resource-oriented Music Therapy for Psychiatric Patients With Low Therapy MotivationCompletedNCT00137189Not applicable
• Nicotine and Cotinine Levels in Smokers With Schizophrenia and Schizoaffective Disorder - 2CompletedNCT00135772

← Schizophrenia Spectrum and Other Psychotic Disorders overview